Chapter 73

Abstract

Abstract

1. Essential pentosuria is an inborn error of metabolism in which 1.0 to 4 g of the pentose L-xylulose is excreted in the urine each day. It is a benign disturbance that occurs principally in Jews and behaves genetically as an autosomal-recessive characteristic.

2. This disorder bears no relationship to diabetes mellitus and is easily distinguished from several other varieties of pentosuria in which milligram quantities of a number of pentoses other than L-xylulose appear in the urine.

3. Essential pentosuria is the result of a defect in the glucuronic acid oxidation pathway. In this route of carbohydrate metabolism the carboxyl carbon atom of D-glucuronic acid is removed in a series of reactions, giving rise to the pentose L-xylulose. The latter may then be converted to its stereoisomer, D-xylulose, which, in turn, may be phosphorylated. D-xylulose-5-phosphate may participate in reactions of the pentose phosphate pathway which lead to its conversion to hexose phosphate. (Glucuromic acid→gulonic acid→L-xylulose→xylitol→D-xylulose→ pentose phosphate pathway→hexose phosphate.) The glucuronic acid oxidation pathway serves no essential function in humans.

4. The block results from reduced activity of the nicotinamide adenine dinucleotide phosphate (NADP)-linked xylitol dehydrogenase, the enzyme that catalyzes the conversion of L-xylulose to xylitol.

5. The heterozygote can be recognized by demonstrating either an intermediate level of erythrocyte activity of xylitol dehydrogenase or increased urinary or serum L-xylulose, or both, in a glucuronolactone loading test.

6. Two previously unreported inborn errors of metabolism occur in the reversible part of the pentose phosphate pathway. Deficiency of ribose-5-phosphate isomerase has been described in one patient who suffered from a progressive leukoencephalopathy and developmental delay. Transaldolase deficiency has been diagnosed in two unrelated families in whiupdt the proband presented in the newborn period with liver problems. (See Supplement: Ribose-5-Phosphate Isomerase Deficiency and Transaldolase Deficiency.)

This chapter is reprinted from the fourth edition with an addendum by the editors as there have not been substantial developments in the area.

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

OMMBID Full Site: One-Year Subscription

Connect to the full suite of OMMBID content including new and revised chapters that reflect the latest research, image galleries, clinical phenotypes, and more.